1. Impact of time of onset of symptom of ST-segment elevation myocardial infarction on 1-year rehospitalization for heart failure and mortality
- Author
-
Tian H. Koh, Mervyn H. H. Chan, Huay C. Tan, Ling L. Foo, Mark Y. Chan, Huili Zheng, Aaron Sung Lung Wong, Terrance Chua, Jack Wei Chieh Tan, Derek J. Hausenloy, Khim Leng Tong, Khung Keong Yeo, Chee W. Lee, Valeria Paradies, Philip Wong, Soo Tek Lim, Heerajnarain Bulluck, and David Foo
- Subjects
medicine.medical_specialty ,business.industry ,Incidence (epidemiology) ,medicine.medical_treatment ,Percutaneous coronary intervention ,030204 cardiovascular system & hematology ,medicine.disease ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Diabetes mellitus ,Heart failure ,medicine ,Cardiology ,ST segment ,Population study ,cardiovascular diseases ,030212 general & internal medicine ,Myocardial infarction ,Risk factor ,Cardiology and Cardiovascular Medicine ,business - Abstract
Circadian patterns in ST-segment elevation myocardial infarction (STEMI) patients have been previously reported, but little is known about the impact of time dependence of symptom onset on long-term prognosis. Our study population consisted of 11,731 STEMI patients treated by primary percutaneous coronary intervention (PPCI), enrolled in the Singapore Myocardial Infarction Registry (SMIR). Analysis of STEMI incidence trends over the 24-hour period showed the highest rate of symptom onset in the morning, with the peak incidence at 09:00 am . Patients with symptom onset in between 00:00 am -5:59 am showed the highest prevalence of diabetes (P = .010) and anterior STEMI (P pm -11:59 pm and 00:00 am -05:59 am having an estimated 30% to 50% higher risk of rehospitalization for HF at 1 year. Moreover, symptom onset remained a predictor of worse prognosis only in the subgroup of patients with symptoms lasting longer than 120 minutes. The results of this study demonstrate for the first time that rehospitalization for HF in STEMI patients treated with PPCI has a dependence on the time of onset of symptoms, with prolonged ischemia time playing a pivotal role. This may be an additional risk factor to identify those who warrant closer monitoring and more rigorous optimization of their treatment at follow-up, to improve their outcomes.
- Published
- 2020
- Full Text
- View/download PDF